Literature DB >> 17591537

Renal manifestations of plasma cell disorders.

Nelson Leung1, S Vincent Rajkumar.   

Abstract

Mesh：

Year:  2007        PMID： 17591537     DOI： 10.1053/j.ajkd.2007.05.007

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  11 in total

1.  Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange.

Authors:  Mayuko Kawabe; Izumi Yamamoto; Ai Katsuma; Naomi Hayashi; Yo Komatsuzaki; Yasuyuki Nakada; Akihiro Shimizu; Yudo Tanno; Ichiro Ohkido; Nobuo Tsuboi; Kazuhito Suzuki; Takaki Shimada; Yoji Ogasawara; Katsuki Sugiyama; Keisuke Aiba; Takashi Yokoo
Journal:  CEN Case Rep       Date:  2016-08-11

2.  Unusual morphology of amyloid cast nephropathy in renal biopsy portending poor prognosis.

Authors:  Meyyappa Devan Rajagopal; Rajesh Nachiappa Ganesh; Sreejith Parameswaran; Dhanin Puthiyottil
Journal:  BMJ Case Rep       Date:  2018-12-22

3.  Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases.

Authors:  Nelson Leung; Morie Gertz; Robert A Kyle; Fernando C Fervenza; Maria V Irazabal; Alfonso Eirin; Shaji Kumar; Stephen S Cha; S Vincent Rajkumar; Martha Q Lacy; Steve R Zeldenrust; Francis K Buadi; Suzanne R Hayman; Samih H Nasr; Sanjeev Sethi; Marina Ramirez-Alvarado; Thomas E Witzig; Sandra M Herrmann; Angela Dispenzieri
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

4.  Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

Authors:  Sanjeev Sethi; Ladan Zand; Nelson Leung; Richard J H Smith; Dragan Jevremonic; Sandra S Herrmann; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

5.  Treating myeloma cast nephropathy without treating myeloma.

Authors:  Nelson Leung
Journal:  J Clin Invest       Date:  2012-04-09       Impact factor: 14.808

Review 6.  Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist.

Authors:  Katherine L Hull; Sherna F Adenwalla; Peter Topham; Matthew P Graham-Brown
Journal:  Clin Med (Lond)       Date:  2021-12-17       Impact factor: 2.659

7.  Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.

Authors:  Taxiarchis V Kourelis; Shaji K Kumar; Morie A Gertz; Martha Q Lacy; Francis K Buadi; Suzanne R Hayman; Steven Zeldenrust; Nelson Leung; Robert A Kyle; Stephen Russell; David Dingli; John A Lust; Yi Lin; Prashant Kapoor; S Vincent Rajkumar; Arleigh McCurdy; Angela Dispenzieri
Journal:  J Clin Oncol       Date:  2013-10-21       Impact factor: 44.544

8.  Differences in immunoglobulin light chain species found in urinary exosomes in light chain amyloidosis (Al).

Authors:  Marina Ramirez-Alvarado; Christopher J Ward; Bing Q Huang; Xun Gong; Marie C Hogan; Benjamin J Madden; M Cristine Charlesworth; Nelson Leung
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

9.  Encephalopathy Induced by Preventive Administration of Acyclovir in a Man with Symptomatic Multiple Myeloma and Renal Dysfunction.

Authors:  Kazuma Sugimoto; Tsuneaki Kenzaka; Ryu Sugimoto; Akihito Kitao; Hozuka Akita
Journal:  Int J Gen Med       Date:  2021-02-11

Review 10.  Pathogenesis of renal failure in multiple myeloma: any role of contrast media?

Authors:  Michele Mussap; Giampaolo Merlini
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.